An intravenous insulin protocol designed for pregnancy reduces neonatal hypoglycaemia following betamethasone administration in women with gestational diabetes
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Aims: Marked hyperglycaemia is common following betamethasone administration in women with gestational diabetes (GDM), and may contribute to neonatal hypoglycaemia. Validated protocols to deliver glycaemic stability following betamethasone are lacking. We hypothesized that an intravenous insulin (IVI) protocol for pregnancy‐specific glycaemic targets (Pregnancy‐IVI) would achieve greater at‐target glycaemic control than a generic adult intravenous insulin protocol (Adult‐IVI), and may reduce neonatal hypoglycaemia. Methods: A retrospective cohort study of the performance Adult‐IVI and Pregnancy‐IVI following betamethasone in GDM, sequentially implemented at a tertiary hospital, without change in indication for IVI. Cases were identified by electronic record search. Primary outcome was percentage of on‐IVI time with at‐target glycaemia [blood glucose level (BGL) 3.8–7 mmol/l]. Secondary outcomes were time with critical hyperglycaemia (BGL > 10 mmol/l), occurrence of maternal hypoglycaemia (BGL < 3.8 mmol/l), and incidence of neonatal hypoglycaemia (BGL ≤ 2.5 mmol/l) if betamethasone was administered within 48 h of birth. Results: The cohorts comprised 151 women (Adult‐IVI n = 86; Pregnancy‐IVI n = 65). The primary outcome was 68% time‐at‐target [95% confidence interval (CI) 64–71%) for Pregnancy‐IVI compared with 55% (95% CI 50–60%) for Adult‐IVI (P = 0.0002). Critical maternal hyperglycaemia (0% vs. 2%, P = 0.02) and hypoglycaemia (2% vs. 12%, P = 0.02) were both lower with Pregnancy‐IVI than Adult‐IVI. Neonatal hypoglycaemia was less common after Pregnancy‐IVI (29%) than after Adult‐IVI (54%, P = 0.03). A multiple logistic regression model adjusting for potential confounders gave an odds ratio for neonatal hypoglycaemia with Pregnancy‐IVI of 0.27 (95% CI 0.10–0.76, P = 0.01). Conclusions: An IVI protocol designed for pregnancy effectively controlled maternal hyperglycaemia following betamethasone administration in GDM. This is the first intervention to show a reduction in betamethasone‐associated neonatal hypoglycaemia, linked with optimum maternal glycaemic control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antenatal Betamethasone for Women at Risk for Late Preterm Delivery
Gyamfi-Bannerman, C., Thom, E. A., Blackwell, S. C., Tita, A. T. N., Reddy, U. M., Saade, G. R., Rouse, D. J., McKenna, D. S., Clark, E. A. S., Thorp, J. M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1516783 · Cited by 814
Hartling, L., Dryden, D. M., Guthrie, A., Muise, M., Vandermeer, B., & Donovan, L. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-2-201307160-00661 · Cited by 395
Mathiesen, E. R., Christensen, A. L., Hellmuth, E., Hornnes, P., Stage, E., & Damm, P. (2002) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.2002.810906.x · Cited by 100
Management of the Insulin-Dependent Diabetic During Labor and Delivery
Miodovnik, M., Mimouni, F., Tsang, R., Skillman, C., Siddiqi, T., Butler, J., & Holroyde, J. (1987) · American Journal of Perinatology · doi:10.1055/s-2007-999750 · Cited by 58
Insulin management during labour and delivery in mothers with diabetes
Lean, M. E. J., Pearson, D. W. M., & Sutherland, H. W. (1990) · Diabetic Medicine · doi:10.1111/j.1464-5491.1990.tb01352.x · Cited by 57
ANDERSEN, O., HERTEL, J., SCHMØLKER, L., & KÜHL, C. (1985) · Acta Paediatrica · doi:10.1111/j.1651-2227.1985.tb10963.x · Cited by 54
Impact of different glycaemic treatment targets on pregnancy outcomes in gestational diabetes
Abell, S. K., Boyle, J. A., Earnest, A., England, P., Nankervis, A., Ranasinha, S., Soldatos, G., Wallace, E. M., Zoungas, S., & J Teede, H. (2019) · Diabetic Medicine · doi:10.1111/dme.13799 · Cited by 20
Dashora, U. K., & Taylor, R. (2004) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.01026_21_3.x-i1 · Cited by 15
Cited by
Dashora, U., Levy, N., Dhatariya, K., Willer, N., Castro, E., Murphy, H. R., & the Joint British Diabetes Societies In Patient group (2022) · Diabetic Medicine · doi:10.1111/dme.14744 · Cited by 51
Tuohy, J. F., Bloomfield, F. H., Crowther, C. A., & Harding, J. E. (2021) · PLOS ONE · doi:10.1371/journal.pone.0246175 · Cited by 36
Rowe, C. W., Watkins, B., Brown, K., Delbridge, M., Addley, J., Woods, A., & Wynne, K. (2021) · Diabetic Medicine · doi:10.1111/dme.14489 · Cited by 16
Self-citationRowe, C. W., Rosee, P., Sathiakumar, A., Ramesh, S., Qiao, V., Huynh, J., Dennien, G., Weaver, N., & Wynne, K. (2024) · Diabetic Medicine · doi:10.1111/dme.15262 · Cited by 6
“13,14 This study has some limitations.”
BackgroundResultInfluentialSelf-citationKatz, A., Shulkin, A., Housni, A., Roy‐Fleming, A., Rabasa‐Lhoret, R., Yale, J., Tsoukas, M. A., Peters, T. M., & Brazeau, A. (2026) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.70465 · Cited by 3
Metadata
- Authors
- Rowe, C. W., Putt, E., Brentnall, O., Gebuehr, A., Allabyrne, J., Woods, A., & Wynne, K.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2018-12-10
- Volume
- 36
- Issue
- 2
- Pages
- 228-236
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W2901521403
- Cited by
- 20
- References
- 8
- FWCI
- 2.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.